Abstract
Portal hypertension, defined as sustained elevation of the portal pressure above 12 mmHg, can arise from a myriad of causes. In Western countries, the most common cause is alcoholic liver cirrhosis, whereas in Asia, and developing countries, it is postnecrotic cirrhosis (from viral hepatitis) and schistosomiasis. The adverse effects of chronic portal hypertension include the formation of esophageal, and extraesophageal varices, ascites, splenomegaly with hypersplenism, hepatorenal syndrome, and hepatic encephalopathy. Hemorrhage from gastroesophageal varices is the most lethal of these complications. Thus, its prevention and treatment has assumed paramount importance in the management of these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Francis R, et al. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319: 983 - 989.
Gores GJ, Wiesner RH, Dickson ER, et al. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence on survival. Gastroenterology 1989; 96: 1552 - 1559.
Graham D, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800 - 809.
Child CG. Eck' s fistula. Surg Gynecol Obstet. 1953;96:375-376. Originally published in Russian: Eck NV. K voprosu o perevyazkie vorotnois veni: predvaritelnoye soobshtshjenye. Voen Med J. 1877; 130: 1 - 2.
Donovan AJ, Covey PC. Early history of the portacaval shunt in humans. Surg Gynecol Obstet. 1978;147:423-430. Originally published in French: Vidal. Traitment chirurgical des ascites dans les cirrhoses du foie. 16th Cong Fr Chir 1903; 16: 294 - 304.
Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies. Ann Surg 1945; 122: 449 - 475.
Linton RR, Jones CM, Volwiler W. Portal hypertension: the treatment by splenectomy and splenorenal anastomosis with preservation of the kidney. Surg Clin North Am 1947; 27: 1162 - 1170.
Bismuth H, Franco D, Hepp J. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg 1974; 179: 209 - 218.
Sarfeh IJ, Rypins EB, Conroy RM, et al. Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983; 197: 422 - 426.
Rypins EB, Mason GR, Conroy RM, et al. Predictability and maintenance of portal flow patterns after small-diameter porta-caval H-grafts in man. Ann Surg 1984; 200: 706 - 710.
Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219: 353 - 361.
Paquet KJ, Lazar A, Koussouris P, et al. Mesocaval interposition shunt with small diameter polytetrafluoroethylene grafts in sclerotherapy failure. Brit J Surg 1995; 82: 199 - 203.
Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967; 166: 437 - 455.
D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332 - 354.
van der Vliet JA, De Visser E, Buskens FGM. Changing pattern of portasystemic shunt surgery. Eur J Surg 1995; 161: 877 - 880.
McCormick PA, Burroughs AK. Relation between liver pathology and prognosis in patients with portal hypertension. World J. Surg 1994; 18: 171 - 175.
Millikan WJ, Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding: ten-year follow-up. Ann Surg 1985; 201: 712 - 722.
Warren WD, Millikan WJ, Henderson JM, et al. Ten years portal hypertensive surgery at Emory: results and new perspectives. Ann Surg 1982; 195: 530 - 542.
Inokuchi K, Beppu K, Koyanagi N, et al. Exclusion of nonisolated splenic vein in distal splenorenal shunt for prevention of portal malcirculation. Ann Surg 1984; 200: 711 - 717.
Warren WD, Millikan WJ, Henderson JM, et al. Splenopancreatic disconnection. Improved selectivity of distal splenorenal shunt. Ann Surg 1986; 204: 346 - 355.
Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204: 356 - 363.
Orozco H, Mercado MA. The evolution of portal hypertension surgery. Lessons from 1000 operations and 50 years' experience. Arch Surg 2000; 135: 1389 - 1393.
Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219: 353 - 361.
Millikan WJ, Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten-year follow-up. Ann Surg 1985; 201: 712 - 722.
Mercado MA, Morales-Linares JC, Granados-Garcia J, et al. Distal splenorenal shunt versus 10-mm low-diameter mesocaval shunt for variceal hemorrhage. Am J Surg 1996; 171: 591 - 595.
Richards WO, Pearson TC, Henderson JM, et al. Evaluation and treatment of early hemorrhage of the alimentary tract after selective shunt procedures. Surg Gynecol Obstet 1987; 164: 530 - 536.
Henderson JM, Millikan WJ, Galloway JR. The Emory perspective of the distal splenorenal shunt in 1990. Am J Surg 1990; 160: 54 - 59.
Richards WO, Pearson TC, Henderson JM, et al. Evaluation and treatment of early hemorrhage of the alimentary tract after selective shunt procedures. Surg Gynecol Obstet 1987; 164: 530.
Henderson JM, Gong-Liang J, Galloway J, et al. Portaprival collaterals following distal splenorenal shunt: incidence, magnitude and associated portal perfusion changes. J Hepatol 1985; 1: 649 - 661.
Henderson JM, Warren WD, Millikan WJ, et al. Distal splenorenal shunt with splenopancreatic disconnection: a four year assessment. Ann Surg 1989; 210: 332 - 341.
Orozco H, Mercado MA, Takahashi T, et al. Survival and quality of life after portal blood flow preserving procedures in patients with portal hypertension and liver cirrhosis. Am J Surg 1994; 168: 10 - 14.
Collins JC, Rypins EB, Sarfeh U. Narrow-diameter portacaval shunts for management of variceal bleeding. World J Surg 1994; 18: 211 - 215.
Paquet KJ, Lazar A, Koussouris P, et al. Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Brit J Surg 1995; 82: 199 - 203.
Rosemurgy AS, McAllister EW, Kearney RE. Prospective study of a prosthetic H-graft portacaval shunt. Am J Surg 1991; 161: 159.
Spina GP, Henderson JM, Rikkers LF, et al. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention variceal bleeding: a meta-analysis of 4 randomized clinical trials. J Hepatol 1992; 16: 338.
Snady H. The role of sclerotherapy in the treatment of esophageal varices: personal experience and a review of randomized trials. Am J Gastroenterology 1987; 82: 813 - 822.
Rikkers LF, Jin G, Burnett DA, et al. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1992; 165: 27 - 33.
Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portasystemic shunts. Gastroenterology 1997; 112: 889 - 898.
Rosemurgy AS, Goode SE, Zwiebel BR, et al. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996; 224: 378 - 386.
Khaitiyar JS, Luthra SK, Prasad N, et al. Transjugular intrahepatic portasystemic shunt versus distal splenorenal shunt - a comparative study. Hepato-gastroenterology 2000; 47: 492 - 497.
Helton WS, Mayes R, Wicks K. Transjugular intrahepatic portasystemic shunt versus surgical shunt in good-risk cirrhotic patients. Arch Surg 2001; 136: 17 - 20.
Zacks SL, Sandler RS, Biddle AK, et al. Decision-analysis of transjugular intrahepatic portasystemic shunt versus distal splenorenal shunt for portal hypertension. Hepatology 1999; 29: 1399 - 1405.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chew, D.K.W., Conte, M.S. (2003). Portasystemic Venous Shunt Surgery for Portal Hypertension. In: Wu, G.Y., Aziz, K., Whalen, G.F. (eds) An Internist’s Illustrated Guide to Gastrointestinal Surgery. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-389-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-59259-389-7_24
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-311-4
Online ISBN: 978-1-59259-389-7
eBook Packages: Springer Book Archive